These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
205 related items for PubMed ID: 9864893
41. Addressing barriers to insulin therapy: the role of insulin pens. Magwire ML. Am J Ther; 2011 Sep; 18(5):392-402. PubMed ID: 20838202 [Abstract] [Full Text] [Related]
42. [Application of oral hypoglycemic agents in the therapy of diabetes mellitus]. Toyota T. Nihon Naika Gakkai Zasshi; 1991 Aug 10; 80(8):1205-9. PubMed ID: 1919237 [No Abstract] [Full Text] [Related]
43. Variability in cross-reactivity of novel insulin analogues in immunometric insulin assays. Krull I, Sahli R, Diem P, Stettler C. Diabet Med; 2009 Oct 10; 26(10):1075-6. PubMed ID: 19900243 [No Abstract] [Full Text] [Related]
44. [Cancer more common in diabetes. Maybe the treatment itself also plays a role]. Nilsson PM, Eliasson B. Lakartidningen; 2009 Oct 10; 107(4):170-1. PubMed ID: 20333969 [No Abstract] [Full Text] [Related]
45. Use of a standardized protocol to decrease medication errors and adverse events related to sliding scale insulin. Donihi AC, DiNardo MM, DeVita MA, Korytkowski MT. Qual Saf Health Care; 2006 Apr 10; 15(2):89-91. PubMed ID: 16585106 [Abstract] [Full Text] [Related]
47. [Combined therapy with insulin and alpha-glucosidase inhibitor]. Watanabe K, Kawamori R. Nihon Rinsho; 1997 Nov 10; 55 Suppl():261-6. PubMed ID: 9434478 [No Abstract] [Full Text] [Related]
48. [The use of highly purified Iletin-II-type porcine insulins and human insulin preparations in clinical practice]. Petunina NA, Balabolkin MI, Mkrtumian AM, Sergeev AV, Nedosugova LV. Ter Arkh; 1993 Nov 10; 65(10):29-31. PubMed ID: 8296229 [Abstract] [Full Text] [Related]
49. The continuation of oral medications with the initiation of insulin therapy in type 2 diabetes: a review of the evidence. McFarland MS, Knight TN, Brown A, Thomas J. South Med J; 2010 Jan 10; 103(1):58-65. PubMed ID: 19996858 [Abstract] [Full Text] [Related]
50. Integrating advances in insulin into clinical practice: Overview of current insulin formulations. Rhinehart AS. J Fam Pract; 2013 Sep 10; 62(9 Suppl Insulin):S4-8. PubMed ID: 24080572 [Abstract] [Full Text] [Related]
51. [Insulin therapy: an ongoing topic]. Waldhäusl W. Wien Med Wochenschr; 1997 Sep 10; 147(9):199. PubMed ID: 9281231 [No Abstract] [Full Text] [Related]
54. Continuation of oral medications when insulin is initiated. Neumiller JJ, Setter SM. South Med J; 2010 Jan 10; 103(1):7-8. PubMed ID: 19996859 [No Abstract] [Full Text] [Related]
55. [Types and choice of the treatment in diabetes mellitus]. Goto Y, Abe R, Hori S. Nihon Rinsho; 1990 Dec 10; 48 Suppl():803-9. PubMed ID: 2128349 [No Abstract] [Full Text] [Related]
56. [Administration of insulin in type 1 diabetes]. Selam JL, Slama G. Rev Prat; 1992 May 01; 42(9):1084-9. PubMed ID: 1496234 [Abstract] [Full Text] [Related]
57. Intensive insulin therapy in patients with type 2 diabetes. Bering B, Devendra D. Lancet; 2008 Aug 30; 372(9640):716-7; author reply 717-8. PubMed ID: 18761218 [No Abstract] [Full Text] [Related]
58. Dead-in-bed syndrome in diabetes mellitus and hypoglycaemic unawareness. Hanas R. Lancet; 1997 Aug 16; 350(9076):492-3. PubMed ID: 9274591 [No Abstract] [Full Text] [Related]
59. [Granulomatous dermatitis caused by surfen in diabetics treated with Insulin-depot-S-Richter]. Jermendy G, Szabó E. Orv Hetil; 1989 Aug 20; 130(34):1825-8. PubMed ID: 2528707 [Abstract] [Full Text] [Related]
60. [Switzerland changes from U-40 to U-100 insulin]. Bürgi U, Egger M, Teuscher A. Schweiz Med Wochenschr; 1988 Aug 09; 118(31-32):1125-9. PubMed ID: 3051336 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]